Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-107,609
Closed -$6.56M 26
2017
Q3
$6.56M Sell
107,609
-95,824
-47% -$5.81M 1.27% 21
2017
Q2
$12.4M Sell
203,433
-19,267
-9% -$1.17M 2.56% 18
2017
Q1
$14.7M Sell
222,700
-88,556
-28% -$5.37M 2.88% 17
2016
Q4
$17.6M Hold
311,256
2.64% 17
2016
Q3
$18.5M Hold
311,256
2.98% 17
2016
Q2
$17.1M Hold
311,256
2.87% 17
2016
Q1
$15.7M Sell
311,256
-7,860
-2% -$385K 2.64% 16
2015
Q4
$16.1M Buy
+319,116
New +$16.1M 2.58% 15

Other funds holding MRK

PM Capital's MRK Position: Q4 2017 in Review

PM Capital sold out of Merck (MRK) in Q4 2017, closing a stake of 107,609 shares — an estimated $6.56M sold.

PM Capital first reported a position in MRK in Q4 2015 and held it in 8 quarters. The position peaked at $18.5M in Q3 2016. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • PM Capital reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • PM Capital sold 107,609 Merck shares in Q4 2017, an estimated $6.56M.
  • PM Capital first reported a position in Merck in Q4 2015 and held it in 8 quarters.
  • PM Capital's Merck position peaked at $18.5M in Q3 2016.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on PM Capital's 13F filing for Q4 2017, filed 16 Jan 2018.